NEW YORK (
) hit a new 52-week high Tuesday as it is currently trading at $27.98, above its previous 52-week high of $27.97 with 52,394 shares traded as of 3 p.m. ET. Average volume has been 165,800 shares over the past 30 days.
Synovis Life has a market cap of $312.1 million and is part of the
industry. Shares are up 0.4% year to date as of the close of trading on Monday.
Synovis Life Technologies, Inc., a medical device company, engages in the development, manufacture, and marketing of biological and mechanical products used by surgical specialties for the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. The company has a P/E ratio of 38.3, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
TheStreet Ratings rates Synovis Life as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full
52-week high stocks
or get investment ideas from our